文献速递瓣膜外科

Barlow病微创二尖瓣修复不同技术的五年结局

Five-year outcomes of different techniques for minimally invasive mitral valve repair in Barlow's disease.
PubMed 文献 · Eur J Cardiothorac Surg · 2024-01-01

该研究纳入2001至2020年间接受微创二尖瓣手术的Barlow病患者246例,按所用技术分为单纯瓣环成形术、附加人工腱索和瓣叶切除三组。三组手术安全性(P=0.774)和主要复合终点(P=0.244)均无显著差异,手术成功率为93.5%,单纯瓣环成形组最低(77.1%),且该组转为二尖瓣置换的比例增加(P<0.001)。

要点

  • 三种技术在Barlow病微创二尖瓣修复中5年结果相当。
  • 手术成功率93.5%,单纯瓣环成形组最低为77.1%。
  • 单纯瓣环成形组转为二尖瓣置换的比例增加(P<0.001)。

核心结论

  • 单纯瓣环成形术、附加人工腱索和瓣叶切除术在Barlow病患者微创二尖瓣手术中均为可行技术,5年结果相当。
  • 鉴于瓣环成形组转换率增加,不应将病理过度简化。

研究设计与样本

  • 连续病例分析,纳入2001年至2020年间因Barlow病接受微创二尖瓣手术的患者246例(n=246)。
  • 按所用手术技术分组:单纯瓣环成形术、附加人工腱索或瓣叶切除术。
  • 主要终点为改良二尖瓣学术研究联盟复合终点:5年内死亡、因修复失败再手术或再发重度二尖瓣反流。
  • 次要终点包括30天内的手术成功和安全性。

主要发现

  • 三种手术技术在手术安全性方面无显著差异(P=0.774)。
  • 主要终点在各组间无显著差异(P=0.244)。
  • 手术成功率为93.5%,单纯瓣环成形组最低(77.1%)。
  • 单纯瓣环成形组转为二尖瓣置换的比例增加(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Barlow's disease is a specific sub-form of mitral valve (MV) disease, characterized by diffuse excessive tissue and multi segment prolapse. The anterolateral mini-thoracotomy represents the standard access for MV regurgitation in many centres. It still remains unclear which surgical technique provides the best results. Therefore, the aim of this study was to compare operative safety and mid-term outcomes after (i) isolated annuloplasty, (ii) use of additional artificial chordae or (iii) leaflet resection in patients suffering from Barlow's disease undergoing minimally invasive MV repair. METHODS: A consecutive series of patients suffering from Barlow's disease undergoing minimally invasive MV surgery between 2001 and 2020 were analysed (n = 246). Patients were grouped and analysed according to the used surgical technique. The primary outcome was a modified Mitral Valve Academic Research Consortium combined end-point of mortality, reoperation due to repair failure or reoccurrence of severe mitral regurgitation within 5 years. The secondary outcome included operative success and safety up to 30 days. RESULTS: No significant difference was found between the 3 surgical techniques with regard to operative safety (P = 0.774). The primary outcome did not differ between groups (P = 0.244). Operative success was achieved in 93.5% and was lowest in the isolated annuloplasty group (77.1%). Conversion to MV replacement was increased in patients undergoing isolated annuloplasty (P < 0.001). CONCLUSIONS: Isolated annuloplasty, use of additional artificial chordae and leaflet resection represent feasible techniques in Barlow patients undergoing minimally invasive MV surgery with comparable 5-year results. In view of the increased conversion rate in the annuloplasty group, the pathology should not be oversimplified.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Pölzl L, Gollmann-Tepeköylü C, Nägele F, et al. Five-year outcomes of different techniques for minimally invasive mitral valve repair in Barlow's disease. Eur J Cardiothorac Surg. 2024. PMID: 38781502. doi:10.1093/ejcts/ezae213

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。